Genetics of Cystic Fibrosis

Cystic fibrosis is a genetic disorder caused by the dysfunction of a protein that transports sodium and chloride across cell membranes. This protein is called the cystic fibrosis transmembrane conductance regulator (CFTR). Mutation of the CFTR gene gives rise to a protein that lets too much salt and not enough water into the cells, causing mucus to be become thick and sweat to become salty.

A thick, sticky mucus builds up in the respiratory and digestive passageways, which gives rise to symptoms of the condition. Ducts in the pancreas and liver become blocked and the lungs are affected by recurrent infections.

Inheritance of the abnormal CFTR gene

Cystic fibrosis is inherited in an autosomal recessive fashion, which means a person has to inherit two abnormal genes in order for the disease to develop. Everyone inherits two CFTR genes, one from the mother and one from the father. When a person inherits one abnormal copy of the CFTR gene, he or she is a termed a carrier. If that person has a baby with another carrier of a defective CFTR gene, one of the following will apply:

  • There is a one-in-four chance that the child will not inherit either of the faulty genes and will have two healthy CFTR genes
  • There is one-in-two chance that the child will inherit one faulty gene, making them a carrier
  • There is one-in-four chance that the child will inherit both the mutated genes and develop cystic fibrosis

Inheritance Pattern for Cystic Fibrosis
Cystic Fibrosis Inheritance Pattern
Source: National Heart, Lung, and Blood Institute


In the United Kingdom, 1 person in every 25 carries the faulty gene for cystic fibrosis. In the United States of America, nearly 12 million people have one faulty gene or are carriers for the disease. In the United States, 1 in every 3700 babies born has cystic fibrosis.

The CFTR gene lies on the seventh chromosome and over 1000 different mutations have been discovered. The most common mutation is the ∆F508, which is seen in two thirds of all cystic fibrosis cases worldwide. The mutation is more common among people of northern European descent.

Further Reading

Last Updated: Jan 18, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, January 18). Genetics of Cystic Fibrosis. News-Medical. Retrieved on February 29, 2024 from

  • MLA

    Mandal, Ananya. "Genetics of Cystic Fibrosis". News-Medical. 29 February 2024. <>.

  • Chicago

    Mandal, Ananya. "Genetics of Cystic Fibrosis". News-Medical. (accessed February 29, 2024).

  • Harvard

    Mandal, Ananya. 2023. Genetics of Cystic Fibrosis. News-Medical, viewed 29 February 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Enterprise Therapeutics closes £26 million ($33.1 million) Series B follow-on financing